Heterozygous mutations in the FH gene can lead to FH-deficient RCC, predisposing individuals to aggressive forms of renal cell carcinoma and other tumors (Zyla and Hodgson, 2021). The gene discussed is FH; the disease is hereditary clear cell renal cell carcinoma.